SERUM-SOLUBLE INTERLEUKIN-6 RECEPTOR IN MRL/LPR MISE IS ELEVATED WITH AGE AND MEDIATES THE INTERLEUKIN-6 SIGNAL

被引:103
作者
SUZUKI, H
YASUKAWA, K
SAITO, T
NARAZAKI, M
HASEGAWA, A
TAGA, T
KISHIMOTO, T
机构
[1] OSAKA UNIV,SCH MED,DEPT MED 3,1-1-50 FUKUSHIMA,FUKUSHIMA KU,OSAKA 553,JAPAN
[2] TOSOH CORP,BIOTECHNOL RES LAB,KANAGAWA,JAPAN
[3] OSAKA UNIV,INST MOLEC & CELLULAR BIOL,OSAKA,JAPAN
[4] UNIV TOKYO,FAC AGR,DEPT VET INTERNAL MED,TOKYO 113,JAPAN
关键词
INTERLEUKIN-6; SOLUBLE INTERLEUKIN-6 RECEPTOR; MRL-LPR; AUTOIMMUNE DISEASE;
D O I
10.1002/eji.1830230515
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The characteristics of soluble interleukin-6 receptor (sIL-6R) in murine sera were examined. To investigate a relationship between serum sIL-6R level and autoimmune diseases, quantitative analysis of serum sIL-6R in MRL/lpr mice was performed by an enzyme-linked immunosorbent assay. The serum sIL-6R level in MRL/lpr mice of both sexes was below the detection limit (< 1.0 ng/ml) at 8 weeks of age, but it increased in accordance with age and reached 42 +/- 9.3 ng/ml in female and 31 +/- 13 ng/ml in male mice at 30 weeks of age. In MRL/+ mice, although an age-associated increase in serum sIL-6R level was observed, it was much less extensive than that in MRL/lpr mice. Elevated serum sIL-6R level at the age of 30 weeks was observed in female and male (NZB x NZW)F1 mice (32 +/- 10 ng/ml and 17 +/- 5.0 ng/ml, respectively), and male BXSB/Mpj Yaa mice (42 +/- 18 ng/ml), suggesting that elevated serum sIL-6R in aged mice is one of the characteristics of autoimmune-prone mice. Quantitative analysis of serum IL-6 in MRL/lpr revealed that the serum sIL-6R level correlated well with the serum IL-6 level. We also showed that sIL-6R in the sera from MRL/lpr mice could mediate the IL-6 functions through the IL-6 signal-transducing receptor component gp130, suggesting that elevated production of sIL-6R may partly contribute to development of autoimmune disease in MRL/lpr mice.
引用
收藏
页码:1078 / 1082
页数:5
相关论文
共 22 条
[1]   SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS [J].
BATAILLE, R ;
JOURDAN, M ;
ZHANG, XG ;
KLEIN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2008-2011
[2]  
BREEN EC, 1990, J IMMUNOL, V144, P480
[3]   RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY [J].
DENIZOT, F ;
LANG, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (02) :271-277
[4]   A RESTRICTED CYTOPLASMIC REGION OF IL-2 RECEPTOR-BETA-CHAIN IS ESSENTIAL FOR GROWTH SIGNAL TRANSDUCTION BUT NOT FOR LIGAND-BINDING AND INTERNALIZATION [J].
HATAKEYAMA, M ;
MORI, H ;
DOI, T ;
TANIGUCHI, T .
CELL, 1989, 59 (05) :837-845
[5]   BIOLOGICAL AND CLINICAL ASPECTS OF INTERLEUKIN-6 [J].
HIRANO, T ;
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
IMMUNOLOGY TODAY, 1990, 11 (12) :443-449
[6]  
HONDA M, 1992, J IMMUNOL, V148, P2175
[7]  
LINKERISRAELI M, 1991, J IMMUNOL, V147, P117
[8]   ISOLATION OF AN MESSENGER-RNA ENCODING A SOLUBLE FORM OF THE HUMAN INTERLEUKIN-6 RECEPTOR [J].
LUST, JA ;
DONOVAN, KA ;
KLINE, MP ;
GREIPP, PR ;
KYLE, RA ;
MAIHLE, NJ .
CYTOKINE, 1992, 4 (02) :96-100
[9]   ESTABLISHMENT OF AN INTERLEUKIN 6 (IL 6)/B-CELL STIMULATORY FACTOR 2-DEPENDENT CELL-LINE AND PREPARATION OF ANTI-IL-6 MONOCLONAL-ANTIBODIES [J].
MATSUDA, T ;
HIRANO, T ;
KISHIMOTO, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (06) :951-956
[10]   SOLUBLE INTERLEUKIN-6 RECEPTOR IS RELEASED FROM RECEPTOR-BEARING CELL-LINES INVITRO [J].
NAKAJIMA, T ;
YAMAMOTO, S ;
CHENG, M ;
YASUKAWA, K ;
HIRANO, T ;
KISHIMOTO, T ;
TOKUNAGA, T ;
HONDA, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (04) :373-378